NIHON MEDI-PHYSICS CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Joint Venture
- Established
- 1973-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.nmp.co.jp
Clinical Trials
14
Active:0
Completed:10
Trial Phases
3 Phases
Phase 1:4
Phase 2:6
Phase 3:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Phase 2
6 (42.9%)Phase 1
4 (28.6%)Phase 3
4 (28.6%)Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Nihon Medi-Physics Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT06129422
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸BAMF Health, Grand Rapids, Michigan, United States
🇺🇸Fred Hutchinson Cancer Center, Seattle, Washington, United States
News
No news found